eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma

eIF6 is potential diagnostic and prognostic biomarker that associated with 18F-FDG PET/CT features and immune signatures in esophageal carcinoma

Background: Although eukaryotic initiation factor 6 (eIF6) is a novel therapeutic target, data on its importance in the development of esophageal carcinoma (ESCA) remains limited. This study evaluated the correlation between eIF6 expression and metabolic analysis using fluorine-18 fluorodeoxyglucose...

Full description

Bibliographic Details
Main Authors: Gao, Y. (Author), Ke, C. (Author), Kui, X. (Author), Li, F. (Author), Li, X. (Author), Liu, X. (Author), Pei, Z. (Author), Tan, F. (Author), Wan, H. (Author), Yuan, L. (Author), Zeng, J. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
18F-FDG-PET parameter
eIF6
Esophageal carcinoma
GLUT1
Immune signatures
Prognostic biomarker
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items